SCHEMBL5617350

SCHEMBL5617350

COc1nc2ccccc2nc1NS(=O)(=O)c1ccc(Cl)s1.COc1nc2ccccc2nc1NS(=O)(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCR5 P51681 2/20 0.61
▸ CCR4 P51679 19/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727669 0.93 CCR5 (0.53) CCR5CCR4
SCHEMBL4683809 0.89 CCR5 (0.75) CCR5CCR4
SCHEMBL4681259 0.89 CCR4 (0.74) CCR4
SCHEMBL4683826 0.82 CCR4 (0.72) CCR4
SCHEMBL4682187 0.80 CCR4 (0.69) CCR4
SCHEMBL14041061 0.80 RXFP1 (0.61) CCR4
SCHEMBL4681093 0.79 CCR4 (0.65) CCR4
SCHEMBL4681452 0.79 CCR4 (0.67) CCR4
SCHEMBL1731557 0.78 CCR4 (0.78) CCR4
SCHEMBL4680926 0.77 CCR4 (0.65) CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007503432-A — — 2007-02-22 — — JP claimed
EP-1660461-A1 NOVEL CONDENSED N-PYRAZINYL-SULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES AstraZeneca AB (SE) 2006-05-31 — — EP claimed
WO-2005021513-A1 NOVEL CONDENSED N-PYRAZINYL-SULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2005-03-10 — — WO claimed
Send feedback